From ASH 2013: So far, so good with dasatinib plus chemo in core binding factor AML http://www.oncologypractice.com/news/specialty-meetings-conference-news/american-society-of-hematology-annual-meeting/single-article/so-far-so-good-with-dasatinib-plus-chemo-in-core-binding-factor-aml/4f054f99266e044f225cfd01edec315e.html …
7:05 AM - 18 Dec 2013
0 replies
2 retweets
0 likes
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.